Center-Authored Papers

Filters: Author is Greenberg, Philip  [Clear All Filters]
Journal Article
Stromnes IM, Blattman JN, Tan X, Jeevanjee S, Gu H, Greenberg PD.  2010.  Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.. The Journal of clinical investigation. 120(10):3722-34. Abstract
Stromnes IM, Fowler C, Casamina CC, Georgopolos CM, McAfee MS, Schmitt TM, Tan X, Kim T-D, Choi I, Blattman JN et al..  2012.  Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo.. Journal of immunology (Baltimore, Md. : 1950). 189(4):1812-25. Abstract
Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N et al..  2018.  Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.. Nature communications. 9(1):3868. Abstract
Till BG, Jensen MC, Wang J, Chen EY, Wood BL, Greisman HA, Qian X, James SE, Raubitschek A, Forman SJ et al..  2008.  Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.. Blood. 112(6):2261-71. Abstract
Dossett ML, Teague RM, Schmitt TM, Tan X, Cooper LJ, Pinzon C, Greenberg PD.  2009.  Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCR.. Molecular therapy : the journal of the American Society of Gene Therapy. 17(4):742-9. Abstract
Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD.  2002.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.. Proceedings of the National Academy of Sciences of the United States of America. 99(25):16168-73. Abstract
James SE, Orgun NN, Tedder TF, Shlomchik MJ, Jensen MC, Lin Y, Greenberg PD, Press OW.  2009.  Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice.. Blood. 114(27):5454-63. Abstract
James SE, Greenberg PD, Jensen MC, Lin Y, Wang J, Till BG, Raubitschek AA, Forman SJ, Press OW.  2008.  Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.. Journal of immunology (Baltimore, Md. : 1950). 180(10):7028-38. Abstract
Wölfl M, Greenberg PD.  2014.  Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8(+) T cells.. Nature protocols. 9(4):950-66. Abstract
Finton KAK, Larimore K, Larman BH, Friend D, Correnti C, Rupert PB, Elledge SJ, Greenberg PD, Strong RK.  2013.  Autoreactivity and Exceptional CDR Plasticity (but Not Unusual Polyspecificity) Hinder Elicitation of the Anti-HIV Antibody 4E10.. PLoS pathogens. 9(9):e1003639. Abstract
Till BG, Jensen MC, Wang J, Qian X, Gopal AK, Maloney DG, Lindgren CG, Lin Y, Pagel JM, Budde LE et al..  2012.  CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.. Blood. 119(17):3940-50. Abstract
Oda SK, Daman AW, Garcia NM, Wagener F, Schmitt TM, Tan X, Chapuis AG, Greenberg PD.  2017.  A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T cell function and therapy of murine leukemia.. Blood. 130(22):2410-2419. Abstract
Chou CK, Schietinger A, Liggitt DH, Tan X, Funk S, Freeman GJ, Ratliff TL, Greenberg NM, Greenberg PD.  2012.  Cell-Intrinsic Abrogation of TGF-β Signaling Delays but Does Not Prevent Dysfunction of Self/Tumor-Specific CD8 T Cells in a Murine Model of Autochthonous Prostate Cancer.. Journal of immunology (Baltimore, Md. : 1950). 189(8):3936-46. Abstract
Wang J, Press OW, Lindgren CG, Greenberg P, Riddell S, Qian X, Laugen C, Raubitschek A, Forman SJ, Jensen MC.  2004.  Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(4):577-86. Abstract
Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD et al..  1999.  Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.. Nature medicine. 5(6):677-85. Abstract
Finton K, Jaffe J, Larman B, Larimore K, Friend D, Correnti C, Stuart A, Vanden Bos T, Elledge S, Greenberg P et al..  2013.  Characterizing the Functional Autoreactivity and Polyspecificity of the MPER-Specific bNAb 4E10 and an Ensemble of Its Germline-Encoded Precursors. AIDS Research and Human Retroviruses. 29:A48-A48. Abstract
Chapuis AG, Lee SM, Thompson JA, Roberts IM, Margolin KA, Bhatia S, Sloan HL, Lai I, Wagener F, Shibuya K et al..  2016.  Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.. The Journal of experimental medicine. 213(7):1133-9. Abstract
Larimore K, McCormick MW, Robins HS, Greenberg PD.  2014.  Correction: Shaping of Human Germline IgH Repertoires Revealed by Deep Sequencing. The Journal of Immunology. 192(1):534-534.
Ochsenreither S, Majeti R, Schmitt T, Stirewalt D, Keilholz U, Loeb KR, Wood B, Choi YE, Bleakley M, Warren EH et al..  2012.  Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.. Blood. 119(23):5492-501. Abstract
Berrien-Elliott MM, Jackson SR, Meyer JM, Rouskey CJ, Nguyen T-LM, Yagita H, Greenberg PD, Dipaolo RJ, Teague RM.  2013.  Durable Adoptive Immunotherapy for Leukemia Produced by Manipulation of Multiple Regulatory Pathways of CD8+ T-Cell Tolerance.. Cancer research. 73(2):605-616. Abstract
Provasi E, Genovese P, Lombardo A, Magnani Z, Liu P-Q, Reik A, Chu V, Paschon DE, Zhang L, Kuball J et al..  2012.  Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.. Nature medicine. 18(5):807-815. Abstract
Schreiber H, Greenberg P.  2015.  Editorial overview: Tumour immunology.. Current opinion in immunology. 33:ix-xi.
Demidenko AA, Blattman JN, Blattman NN, Greenberg PD, Nibert ML.  2013.  Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression.. Proceedings of the National Academy of Sciences of the United States of America. 110(20):E1867-76. Abstract
Schmitt TM, Aggen DH, Stromnes IM, Dossett ML, Richman SA, Kranz DM, Greenberg PD.  2013.  Enhanced-affinity murine TCRs for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection.. Blood. 122(3):348-56. Abstract
Greenberg PD, Schreiber RD, Miller LJ.  2016.  Fresh Beginnings.. Cancer immunology research. 4(1):1-2.